Literature DB >> 2831185

Myeloperoxidase deficiency.

W M Nauseef1.   

Abstract

MPO activity is critical for optimal microbicidal activity of normal PMNs. In the absence of MPO, auxiliary mechanisms protect most MPO-deficient hosts from clinically significant sequelae, except for some persons with diabetes mellitus who suffer severe candidal disease. However, given our limited knowledge of the clinical impact of MPO deficiency, histochemical staining of peripheral blood smears or MPO activity of isolated leukocytes should be assessed in patients with unexplained fungal disease or with suspected impaired host defenses. Recently isolated cDNA probes provide important tools for dissecting the molecular and cell biology underlying hereditary MPO deficiency and the link between MPO gene expression and myeloid differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831185

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  24 in total

Review 1.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

Review 2.  The use of myeloperoxidase as a risk marker for atherosclerosis.

Authors:  Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

3.  Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor.

Authors:  L Maródi; C Tournay; R Káposzta; R B Johnston; N Moguilevsky
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 4.  How neutrophils kill microbes.

Authors:  Anthony W Segal
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

5.  Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis.

Authors:  J P Gaut; G C Yeh; H D Tran; J Byun; J P Henderson; G M Richter; M L Brennan; A J Lusis; A Belaaouaj; R S Hotchkiss; J W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

6.  The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

Authors:  Constanze Bergt; Subramaniam Pennathur; Xiaoyun Fu; Jaeman Byun; Kevin O'Brien; Thomas O McDonald; Pragya Singh; G M Anantharamaiah; Alan Chait; John Brunzell; Randolph L Geary; John F Oram; Jay W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 7.  Infections in patients with inherited defects in phagocytic function.

Authors:  Timothy Andrews; Kathleen E Sullivan
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  Interactions of dirithromycin with human polymorphonuclear leukocytes.

Authors:  W L Hand; D L Hand
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

9.  Human neutrophils employ chlorine gas as an oxidant during phagocytosis.

Authors:  S L Hazen; F F Hsu; D M Mueller; J R Crowley; J W Heinecke
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

10.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Authors:  A Daugherty; J L Dunn; D L Rateri; J W Heinecke
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.